Literature DB >> 9815230

Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice.

B C Fries1, A Casadevall.   

Abstract

Serial isolates of Cryptococcus neoformans from patients with chronic infection can exhibit minor karyotype changes as a result of chromosome length polymorphism (CLP). This study investigated whether serial C. neoformans isolates with CLP from 4 patients with AIDS exhibited biologic and phenotypic differences. CLP permits the identification of serial isolates in murine mixed infection. The parameters studied were virulence in mice, capsule size, colony morphology, melanization, protease production, MICs of antifungal drugs, and growth rates in vitro. Two parameters of virulence in mice were studied: persistence in tissue and survival time after lethal infection. Serial C. neoformans isolates were shown to differ in ability to persist in vivo, virulence in a murine infection model, in vitro growth rates at 37 degreesC, and capsule size. Melanin and protease production and MICs of antifungal drugs were comparable for serial isolates. These observations suggest microevolution of C. neoformans during human infection. This process may allow the fungal population to change, escape eradication by the immune system, and thus cause chronic infections.

Entities:  

Mesh:

Year:  1998        PMID: 9815230     DOI: 10.1086/314521

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  It infects me, it infects me not: phenotypic switching in the fungal pathogen Cryptococcus neoformans.

Authors:  C A D'Souza; J Heitman
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.

Authors:  Neena Jain; Abraham Guerrero; Bettina C Fries
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

3.  Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.

Authors:  Bettina C Fries; Emily Cook; Xiabo Wang; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Eukaryot Cell       Date:  2007-10-19

5.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

6.  Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors.

Authors:  R Blackstock; K L Buchanan; R Cherniak; T G Mitchell; B Wong; A Bartiss; L Jackson; J W Murphy
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

7.  Aging: an emergent phenotypic trait that contributes to the virulence of Cryptococcus neoformans.

Authors:  Tejas Bouklas; Bettina C Fries
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

8.  Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.

Authors:  B C Fries; D L Goldman; R Cherniak; R Ju; A Casadevall
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 9.  Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Neena Jain; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.